港股异动 | 京东健康(6618.HK)涨超5% 2020年总收入显著增长78.8%
格隆汇3月30日丨京东健康(6618.HK)现报112.8港元,涨5.72%,暂成交1亿港元,最新总市值3591.9亿港元。京东健康昨日晚间发布2020年度业绩称,面对严峻的经济形势和激烈的行业竞争,2020年公司业务依旧保持强劲增长。期内,集团的总收入为194亿元(人民币,下同),同比显著增长78.8%。2020年的平台活跃用户数增至8,980万,相比2019年净增加3,370万,成为集团业务的主要增长驱动力。平台的日均问诊量超过10万,是2019年同期的5倍多。年度非国际财务报告准则盈利7.489亿元,同比增长117.7%。集团总收入的增长主要是由于销售医药和健康产品所得商品收入由2019年的94亿元增加77.8%至2020年的168亿元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.